Need all Congresses? Press Enter for expanded federal results.

S 4222

New Jersey Senate bill in Session 2026-2027.

Status: introduced. Latest action: May 14, 2026.

Generic and biosimilar drugs-improve acess to lower-cost drug.

Bill ID NJ-2026-2027-S-4222
Session 2026-2027
Status introduced
Committee Commerce
Senate introduced 2026-05-14
Summary

Improves access to lower-cost generic and biosimilar drugs.

Sponsor
Johnson, Gordon M.
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-05-14 Introduced Bill introduced
2026-05-14 Status introduced
2026-05-14 Latest Action INT 1RS REF SCM
More Bills From This Sponsor
S 282
John R. Lewis Voter Empowerment Act of New Jersey-establishes
unknown • Senate
S 4179
Responsible Collective Negotiations Act-remove exclusion; instit of higher ed
introduced • Senate
S 438
Medicaid reimbursement rate for brain injury services-establish
in_committee • Senate
S 1250
Alzheimer's disease public awareness campaign-require DHS establish
unknown • Senate
SR 96
NJ-Taiwan sister-st relationship & Taiwan Relations Act anniversary-recognize
introduced • Senate
S 773
Cigarette & tobacco products tax rev-incr amount prov to Comm on Cancer Research
in_committee • Senate